Testing effectiveness (Phase 2)Active Not RecruitingNCT05067621
What this trial is testing
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
Who this might be right for
Type 2 Diabetes MellitusImpaired Glucose ToleranceNon-Alcoholic Fatty Liver Disease+1 more
Yale University 60